Clinical Researcher—February 2020 (Volume 34, Issue 2) PEER REVIEWED Alexa Richie, DHSc; Dale Gamble, MHSc; Andrea Tavlarides, PhD; Kate Strok, CCRC, CCRA; Carol Griffin The workforce of the clinical research enterprise continues to change and the demand for experienced professionals at the site, sponsor, and contract research organization (CRO) levels continues to increase. At […]
Clinical Researcher—February 2020 (Volume 34, Issue 2) PEER REVIEWED Tiago Silva, MSc; Alexandra Parnell, MSc; Christopher Bamford, PhD; Catherine Paulen, PharmD; Simona Francisconi, MSc; Jaclyn Bosco, PhD, MPH; Louise Parmenter, PhD, MSc [Editor's Note: After Table 1, the other Tables referred to in this article may be seen in a PDF version here.] […]
Clinical Researcher—February 2020 (Volume 34, Issue 2) SPECIAL FEATURE Rob Aspbury, PhD It’s hard to imagine that 37 leading, global biopharmaceutical companies would be willing to partner to develop a new technology and progress a scientific field, but that is exactly what the members of the Simcyp Consortium have achieved. Working together in a […]
Clinical Researcher—February 2020 (Volume 34, Issue 2) SITE STRATEGIES Cerdi Beltre; Geoffrey Schick, MBA, CHRC When you oversee a clinical research program, a research site, or a health system, you take reputational risks if your research community is not well supported. Failure to provide appropriate access to training resources for each team member may […]
Clinical Researcher—February 2020 (Volume 34, Issue 2) RECRUITMENT & RETENTION Henry Anhalt, DO In the world of diabetes, researchers have discovered that diabetes drugs have cardiovascular implications. The U.S. Food and Drug Administration (FDA) wants long-term follow-up studies to ensure safety—the virtual study model is perfect for that. It was only a decade ago […]
